Allergy Therapeutics is a Europe-based speciality pharmaceutical company focused upon the treatment and prevention of allergy. AT has an existing sales base of approximately £19 million per annum, an MHRA-approved manufacturing capability and an established sales and marketing infrastructure in several major European markets. In addition, the company has a number of novel compounds which have already undergone initial clinical evaluation and once registered could potentially revolutionise the treatment of allergy.
| Description | Report Date | Published |
|---|---|---|
| Annual Report 2012 | 30-06-2012 | 14-09-2012 |
| Annual Report 2011 | 01-07-2011 | 16-09-2011 |
| Annual Report 2009 | 01-07-2009 | 17-09-2010 |
| Annual Report 2009 | 30-06-2009 | 18-09-2009 |
| Annual Report 2008 | 30-06-2008 | 22-09-2008 |
| Annual Report 2007 | 30-06-2007 | 24-09-2007 |
| Annual Report 2006 | 30-06-2006 | 11-09-2006 |
| Annual Report 2005 | 30-06-2005 | 12-09-2005 |
| Annual Report 2004 | 30-06-2004 | 05-08-2004 |
| Description | Report Date | Published |
|---|---|---|
| Interim Report 2011 | 31-12-2011 | 29-03-2012 |
| Interim Report 2010 | 31-12-2010 | 26-03-2011 |
| Interim Report 2009 | 31-12-2009 | 01-03-2010 |
| Interim Report 2008 | 31-12-2008 | 31-03-2009 |
| Interim Report 2007 | 31-12-2007 | 17-03-2008 |
| Interim Report 2006 | 31-12-2006 | 27-02-2007 |
| Interim Report 2005 | 31-12-2005 | 24-03-2006 |
| Interim Report 2004 | 31-12-2004 | 08-03-2005 |
| Description |
|---|
| Investor Relations |
| Presentations |
| Events Calendar |
| Home |
| Results Index |
| Press Releases |
| Contacts |
| Type | Dividend | Payment Date |
|---|